Abstract
Most of the breast cancer deaths occur when cancer cells depart from their tumour of origin and spread systemically and colonise distant organs. The present study was to find out whether punarnavine, the quinolizidine alkaloid, with already proven antimetastatic effect on spontaneous B16F10 pulmonary metastasis has got any effect on a drastic organ-specific breast cancer spread. For the study, we selected a syngenic mouse 4T1 breast tumour model that mimics stage four of human breast cancer. The metastatic progression of 4T1 to lymph nodes, lungs, and liver was reduced by punarnavine (40 mg/kg body weight) administration in BALB/c mice. This was evident from the histopathology of these organs as well as from the reduction in the metastatic cell density of cultured 6-thioguanine-resistant 4T1 cells in the punarnavine-treated group compared to the control group. There was also a significant (p < 0.0001) inhibition of the primary breast tumour growth in the orthotopic site of induction with a simultaneous increase (p < 0.0001) in the life span of treated animals. The assessment of biochemical parameters such as hydroxyproline, hexosamine, uronic acid, sialic acid and γ-glutamyl transferase and the analysis of various cytokines VEGF, IL-1β, TNF-α and GM-CSF showed a similar pattern of reduction in punarnavine (p < 0.0001) treated group compared to the control group. The gene expression study revealed the inhibitory effect of punarnavine on the major genes MMP-2, MMP-9, TIMP-1, TIMP-2 and VEGF involved in the metastatic process. These findings undeniably proved the potential of this quinolizidine alkaloid in combating breast tumour development and its progression in the studied murine model.
Similar content being viewed by others
Abbreviations
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- FBS:
-
Foetal bovine serum
- HBSS:
-
Hanks balanced salt solution
- ELISA:
-
Enzyme-linked immunosorbent assay
- IL-1β:
-
Interleukin-1β
- TNF-α:
-
Tumour necrosis factor-α
- GMCSF:
-
Granulocyte monocyte colony-stimulating factor
- VEGF:
-
Vascular endothelial growth factor
- MMP:
-
Matrix metalloproteinase
- TIMP:
-
Tissue inhibitor of matrix metalloproteinase
- GAPDH:
-
Glyceraldehyde 3-phosphate dehydrogenase
- TNBC:
-
Triple-negative breast cancer
References
Agarwal RR, Dutt SS (1935) Chemical examination of punarnava or Boerhavia diffusa Linn II, isolation of an alkaloid punarnavine. Proc Acad Sci United Prov Agra Audh India 5:240–242
Aher V, Chattopadhyay P, Goyary D, Veer V (2013) Evaluation of the genotoxic and antigenotoxic potential of the alkaloid punarnavine from Boerhavia diffusa. Planta Med 79:939–945
Bergman I, Loxley R (1970) The determination of hydroxyproline in urine hydrolysates. Clin Chim Acta 27:347–349
Bibby MC (2004) Orthotopic models of cancer for preclinical drug evaluation. Eur J Cancer 40:852–857
Bitter T, Muir HM (1962) A modified uronic acid carbazole reaction. Anal Biochem 4:330–334
Braithwaite D, Demb J, Henderson ML (2016) Optimal breast cancer screening strategies for older women: current perspectives. Clin Interv Aging 11:111–125
Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283
Büll C, Stoel MA, den Brok MH, Adema GJ (2014) Sialic acids sweeten a tumor’s life. Cancer Res 74:3199–3204
Carlson RW, Allred DC, Anderson BO et al (2009) Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 7:122–192
Chiang AC, Massagué J (2008) Molecular basis of metastasis. N Engl J Med 359:2814–2823
Coffelt SB, Kersten K, Doornebal CW et al (2015) IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522:345–348
Dawson J, Smith GD, Boak J, Peters TJ (1979) gamma-Glutamyltransferase in human and mouse breast tumours. Clin Chim Acta 96:37–42
Dhingra D, Valecha R (2014) Evidence for involvement of the monoaminergic system in antidepressant-like activity of an ethanol extract of Boerhavia diffusa and its isolated constituent, punarnavine, in mice. Pharm Biol 52:767–774
DuPré SA, Redelman D, Hunter KW (2007) The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci. Int J Exp Pathol 88:351–360
Eccles SA, Box G, Court W et al (1994) Preclinical models for the evaluation of targeted therapies of metastatic disease. Cell Biophys 24:279–291
Elson LA, Morgan WT (1933) A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 27:1824–1828
Engebraaten O, Vollan HKM, Børresen-Dale A-L (2013) Triple-negative breast cancer and the need for new therapeutic targets. Am J Pathol 183:1064–1074
Greenwell M, Rahman PKSM (2015) Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res 6:4103–4112
Gupta GP, Nguyen DX, Chiang AC et al (2007) Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446:765–770
Ho B-Y, Lin C-H, Apaya MK et al (2012) Silibinin and paclitaxel cotreatment significantly suppress the activity and lung metastasis of triple negative 4T1 mammary tumor cell in mice. J Tradit Complement Med 2:301–311
Hoffman RM (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17:343–359
Hogan-Ryan A, Fennelly JJ, Jones M et al (1980) Serum sialic acid and CEA concentrations in human breast cancer. Br J Cancer 41:587–592
Hussaini SAB, Andola SK, Mahanta A (2015) Study of metastasis in lymphnode biopsies with special reference to immunohistochemistry (IHC) in metastatic breast carcinoma. J Clin Diagn Res 9:13–16
Kalluri R, Weinberg RA (2009) The basics of epithelial–mesenchymal transition. J Clin Invest 119:1420–1428
Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67
Kim S, Takahashi H, Lin W-W et al (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457:102–106
Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol 15:178–196
Lehembre F, Regenass U (2012) Metastatic disease: a drug discovery perspective. Semin Cancer Biol 22:261–271
Manu KA, Kuttan G (2009a) Anti-metastatic potential of Punarnavine, an alkaloid from Boerhavia diffusa Linn. Immunobiology 214:245–255
Manu KA, Kuttan G (2009b) Immunomodulatory activities of Punarnavine, an alkaloid from Boerhavia diffusa. Immunopharmacol Immunotoxicol 31:377–387
Manu KA, Kuttan G (2009c) Punarnavine induces apoptosis in B16F-10 melanoma cells by inhibiting NF-kappaB signaling. Asian Pac J Cancer Prev 10:1031–1037
Nguyen DX, Bos PD, Massagué J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274–284
Oakley GJ III, Tubbs RR, Crowe J et al (2006) HER-2 amplification in tubular carcinoma of the breast. Am J Clin Pathol 126:55–58
Ouzounova M, Lee E, Piranlioglu R et al (2017) Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade. Nat Commun 8:1–13
Pulaski BA, Ostrand-Rosenberg S (2001) Mouse 4T1 Breast tumor model. In: Current protocols in immunology. Wiley, Hoboken, NJ, USA, pp 1–16
Radisky ES, Radisky DC (2010) Matrix metalloproteinase-induced epithelial–mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15:201–212
Saraswati S, Alhaider AA, Agrawal SS (2013) Punarnavine, an alkaloid from Boerhaavia diffusa exhibits anti-angiogenic activity via downregulation of VEGF in vitro and in vivo. Chem Biol Interact 206:204–213
Silva VL, Ferreira D, Nobrega FL, Martins IM (2016) Selection of novel peptides homing the 4T1 CELL line: exploring alternative targets for triple negative breast cancer. PLoS One 11:1–15
Skoza L, Mohos S (1976) Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation. Biochem J 159:457–462
Su S, Liu Q, Chen J et al (2014) A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 25:605–620
Szasz G (1976) Reaction-rate method for gamma-glutamyltransferase activity in serum. Clin Chem 22:2051–2055
Tao K, Li J, Warner J et al (2001) Multiple lysosomal trafficking phenotypes in metastatic mouse mammary tumor cell lines. Int J Oncol 19:1333–1339
Vanharanta S, Massagué J (2013) Origins of metastatic traits. Cancer Cell 24:410–421
Vernon AE, Bakewell SJ, Chodosh LA (2007) Deciphering the molecular basis of breast cancer metastasis with mouse models. Rev Endocr Metab Disord 8:199–213
Wajner SM, Capp C, Brasil BA et al (2014) Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma. Oncol Lett 7:731–737
Wculek SK, Malanchi I (2015) Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528:413–417
Weigelt B, Peterse JL, van’t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591–602
West DC, Hampson IN, Arnold F, Kumar S (1985) Angiogenesis induced by degradation products of hyaluronic acid. Science 228:1324–1326
Wu Y, Deng J, Rychahou PG et al (2009) Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15:416–428
Xiong G, Deng L, Zhu J et al (2014) Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. BMC Cancer 14:1
Yadav L, Puri N, Rastogi V, Satpute P (2015) Tumour angiogenesis and angiogenic inhibitors: a review. J Clin 9:1–5
Zelenay S, van der Veen AG, Böttcher JP et al (2015) Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162:1257–1270
Acknowledgements
The authors express gratitude to the Council of Scientific and Industrial Research (CSIR), Government of India for the senior research fellowship provided to Ms. Gilcy George K.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
George Kallivalappil, G., Kuttan, G. Efficacy of punarnavine in restraining organ-specific tumour progression in 4T1-induced murine breast tumour model. Inflammopharmacol 27, 701–712 (2019). https://doi.org/10.1007/s10787-018-0490-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-018-0490-0